Mrs. Amy J Kocherla, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17432 Highland Ave, Arlington, GA 39813 Phone: 229-725-3135 |
News Archive
In advance of the 41st Union World Conference, the Global Alliance for TB Drug Development (TB Alliance) today announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients. This novel three-drug combination shows promise to treat both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.
Thanks to methods used in fluid mechanics, the course of a pandemic and the effectiveness of government containment measures can be assessed promptly and accurately, and forecasts can be derived.
A new, clinical study confirms that dietary supplementation of nitrate from a natural extract of Amaranthus species nicknamed "red spinach," results in a significant increase in plasma nitrite that ultimately enhances nitric oxide.
KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors – three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy ranging from pre-term birth to genetic conditions.
› Verified 5 days ago